Status:
TERMINATED
Hyperglycemia in Surgical Infections
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Necrotizing Fasciitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory an...
Detailed Description
This is a multi-center explanatory trial of strict glycemic control for surgical patients with necrotizing soft tissue infection (NSTI). The primary objective of this study is to verify feasibility of...
Eligibility Criteria
Inclusion
- Patients will be enrolled at one of the following centers: the LBJ General Hospital (UT-Houston), the Ben Taub General Hospital (Baylor Houston), The Methodist Hospital (Texas Medical Center), or the University of Texas Health Science Center at San Antonio and the Brooke Army Medical Center.
- We will attempt to enroll all eligible patients with a diagnosis of a necrotizing soft tissue infection (NSTI), including Fournier's gangrene, confirmed in the operating room regardless of age, ethnicity or gender.
Exclusion
- Pregnant patients
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00353275
Start Date
August 1 2009
End Date
July 1 2011
Last Update
November 21 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
LBJ General Hospital/ UT health Science Center-Houston
Houston, Texas, United States, 77026/ 77030
2
Brooke Army Medical Center
San Antonio, Texas, United States, 78234